1. Market Research
  2. > Sigmoid Pharma Ltd. - Product Pipeline Review - 2013

Sigmoid Pharma Ltd. - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 31 pages

Sigmoid Pharma Ltd. - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “Sigmoid Pharma Ltd. - Product Pipeline Review - 2013” provides data on the Sigmoid Pharma Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Sigmoid Pharma Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Sigmoid Pharma Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Sigmoid Pharma Ltd. - Brief Sigmoid Pharma Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Sigmoid Pharma Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Sigmoid Pharma Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Sigmoid Pharma Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Sigmoid Pharma Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Sigmoid Pharma Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Sigmoid Pharma Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Sigmoid Pharma Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Sigmoid Pharma Ltd. and identify potential opportunities in those areas.

Table Of Contents

Sigmoid Pharma Ltd. - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Sigmoid Pharma Ltd. Snapshot 5
Sigmoid Pharma Ltd. Overview 5
Key Information 5
Key Facts 5
Sigmoid Pharma Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Sigmoid Pharma Ltd. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Sigmoid Pharma Ltd. - Pipeline Products Glance 11
Sigmoid Pharma Ltd. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Sigmoid Pharma Ltd. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Sigmoid Pharma Ltd. - Drug Profiles 15
AlloCol 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
cyclosporine IR 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
CyCol 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
CyCron 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
Drug For Graft Versus Host Disease 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
Drug For Neurodegeneration 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
SmPill Enabled Combination Products 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
Vaccine For Diarrhoea And Helicobacter Pylori Infections 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
Sigmoid Pharma Ltd. - Pipeline Analysis 23
Sigmoid Pharma Ltd. - Pipeline Products by Therapeutic Class 23
Sigmoid Pharma Ltd. - Pipeline Products By Target 25
Sigmoid Pharma Ltd. - Pipeline Products by Route of Administration 26
Sigmoid Pharma Ltd. - Pipeline Products By Mechanism of Action 27
Sigmoid Pharma Ltd. - Recent Pipeline Updates 28
Sigmoid Pharma Ltd. - Locations And Subsidiaries 29
Head Office 29
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 31
Disclaimer 31

List of Tables

Sigmoid Pharma Ltd., Key Information 5
Sigmoid Pharma Ltd., Key Facts 5
Sigmoid Pharma Ltd. - Pipeline by Indication, 2013 8
Sigmoid Pharma Ltd. - Pipeline by Stage of Development, 2013 9
Sigmoid Pharma Ltd. - Monotherapy Products in Pipeline, 2013 10
Sigmoid Pharma Ltd. - Phase II, 2013 11
Sigmoid Pharma Ltd. - Phase I, 2013 12
Sigmoid Pharma Ltd. - Preclinical, 2013 13
Sigmoid Pharma Ltd. - Discovery, 2013 14
Sigmoid Pharma Ltd. - Pipeline By Therapeutic Class, 2013 24
Sigmoid Pharma Ltd. - Pipeline By Target, 2013 25
Sigmoid Pharma Ltd. - Pipeline By Route of Administration, 2013 26
Sigmoid Pharma Ltd. - Pipeline Products By Mechanism of Action, 2013 27
Sigmoid Pharma Ltd. - Recent Pipeline Updates, 2013 28

List of Figures

Sigmoid Pharma Ltd. - Pipeline by Indication, 2013 7
Sigmoid Pharma Ltd. - Pipeline by Stage of Development, 2013 9
Sigmoid Pharma Ltd. - Monotherapy Products in Pipeline, 2013 10
Sigmoid Pharma Ltd. - Pipeline By Therapeutic Class, 2013 23
Sigmoid Pharma Ltd. - Pipeline Products By Mechanism of Action, 2013 27

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.